Clorox Co
CLX: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$979.00 | Fdq | Kqnxrdkvf |
Clorox Toggling Multiple Levers To Rebuild Margins While Resolutely Focusing on Brand Investments
Business Strategy and Outlook
While volume growth has been hard to come by since the pandemic prompted consumers to scour the shelves for Clorox’s fare, we don’t think consumers are turning their backs on Clorox’s cleaning and disinfecting products, as overall sales remain well above where they were before the pandemic, to the tune of 20%-30% of late. This prowess is further evidenced by its disinfecting wipes offering, which has been gaining market share.